Centauri Therapeutics is a UK-based biotechnology company focused on the discovery and development of life threatening diseases.
Centauri Therapeutics has raised $8.1M in total funding. The most recent round was Series A. The last funding was announced in February 2026.
Centauri Therapeutics's investors include Novo Holdings, Evotec, Innovate UK, Boehringer Ingelheim Venture Fund, CARB-X.
Centauri Therapeutics is headquartered in Alderley Park, United Kingdom.
Centauri Therapeutics is a UK-based biotechnology company focused on the discovery and development of life threatening diseases.
Centauri Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Centauri Therapeutics — Funding & Investors." VCBacked, February 24, 2026, https://www.vcbacked.co/company/centauri-therapeutics. Accessed July 25, 2026.
VCBacked. (2026). Centauri Therapeutics — Funding & Investors. Retrieved July 25, 2026, from https://www.vcbacked.co/company/centauri-therapeutics
{{cite web |title=Centauri Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/centauri-therapeutics |website=VCBacked |access-date=July 25, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated